scispace - formally typeset
F

Frans van Harskamp

Researcher at Erasmus University Rotterdam

Publications -  11
Citations -  3872

Frans van Harskamp is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Dementia & Aphasia. The author has an hindex of 10, co-authored 11 publications receiving 3719 citations.

Papers
More filters
Journal ArticleDOI

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study.

TL;DR: It is suggested that dementia and its two major subtypes Alzheimer's disease and vascular dementia are associated with atherosclerosis and that there is an interaction between apolipoprotein E and Atherosclerosis in the aetiology of Alzheimer’s disease.
Journal ArticleDOI

Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β–amyloid precursor protein gene

TL;DR: A novel base mutation in the same exon of the APP gene which co–segregates in one family with presenile dementia and cerebral haemorrhage due to cerebral amyloid angiopathy is reported, suggesting that the clinically distinct entities can be caused by the same mutation.
Journal ArticleDOI

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

TL;DR: Dementia and subtypes Alzheimer's disease and vascular dementia may be related to atrial fibrillation even if no clinical stokes have occurred, and the relation with dementia was more pronounced in the relatively younger elderly.
Journal ArticleDOI

Incidence and Risk of Dementia: The Rotterdam study

TL;DR: Although the incidence rates of men and women up to age 85 were similar, the lifetime risk of dementia for 55-year-old women was twice as high as for men (0.33 vs. 0.16), reflecting both the higher life expectancy of women and the higher dementia risk at very old age.
Journal ArticleDOI

Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study.

TL;DR: An inverse association between blood pressure and dementia risk in elderly persons on antihypertensive medication is suggested, suggesting they may need higher blood pressure levels to maintain an adequate cerebral perfusion or lower blood pressure may be secondary to brain lesions in preclinical stages of dementia.